Laddar populära aktier...
Endomines' net sales for the first half of the year were roughly as expected, though profitability d...
Administer’s Q2 net sales declined by 1.3% y/y, mainly attributable to the demand for personnel leas...
Marimekko's second-quarter results generally met our expectations.
Redeye comments on Nitro Games' Q2 2024 report, which came in better than expected, both in sales an...
Q2: Revenues 5% above, EBIT of DKK 41m vs. ABGSCe 30m Cutting EBIT guidance on new investments in SD...
First Ovzon-3 order: USD 6.2m from the US DoD 33% upgrade of the last US DoD contract Neutral to est...
Group net sales was EUR 31.7m in Q2 (Nordea est. EUR 30.
Redeye provides a research update following the Q2 2024 report from Precise Biometrics.
Q2 report due Friday, 23 August, at 07:00 CET '24e-'26e EBITA up 2-3%; 7% CAGR '23-'26e 12-9x EBITA ...
Investment management to be main earnings contributor in Q2 Continued weak market activity makes us ...
Redeye remains confident on the case as Railcare showed surprisingly strong sales growth of 24% in Q...
We cut '25e-'26e EBITDA by 28-14% Aurdel restructuring to yield improvements in '25e '25e EV/EBIT of...
11% adj. EBITA miss but improvement already in Q3 '24e adj.
European recovery needed in H2 to meet outlook BTS reiterated its FY outlook of better earnings in 2...
Redeye maintains a positive view of Transtema following a Q2 beating our expectations.
